SHL Stock Overview
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Siemens Healthineers AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €52.62 |
| 52 Week High | €58.16 |
| 52 Week Low | €44.46 |
| Beta | 0.73 |
| 1 Month Change | -5.16% |
| 3 Month Change | 2.73% |
| 1 Year Change | -5.87% |
| 3 Year Change | 12.08% |
| 5 Year Change | 38.95% |
| Change since IPO | 71.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| SHL | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 1.3% | -0.6% | 1.8% |
| 1Y | -5.9% | -9.5% | 2.2% |
Return vs Industry: SHL exceeded the German Medical Equipment industry which returned -9.5% over the past year.
Return vs Market: SHL underperformed the German Market which returned 2.2% over the past year.
Price Volatility
| SHL volatility | |
|---|---|
| SHL Average Weekly Movement | 2.9% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: SHL has not had significant price volatility in the past 3 months.
Volatility Over Time: SHL's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 71,400 | Bernd Montag | www.siemens-healthineers.com |
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.
Siemens Healthineers AG Fundamentals Summary
| SHL fundamental statistics | |
|---|---|
| Market cap | €58.87b |
| Earnings (TTM) | €1.52b |
| Revenue (TTM) | €21.78b |
38.8x
P/E Ratio2.7x
P/S RatioIs SHL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SHL income statement (TTM) | |
|---|---|
| Revenue | €21.78b |
| Cost of Revenue | €13.96b |
| Gross Profit | €7.82b |
| Other Expenses | €6.30b |
| Earnings | €1.52b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | 1.36 |
| Gross Margin | 35.89% |
| Net Profit Margin | 6.97% |
| Debt/Equity Ratio | 89.4% |
How did SHL perform over the long term?
See historical performance and comparison